We are renowned for our expertise and experience with Supplementary Protection Certificates (SPCs), and are often instructed on complex, multi-jurisdictional cases. Our most notable work in this area includes acting in referrals to the European Court of Justice and to the European Free Trade Area court on important issues relating to the scope of SPC that can be granted for biotechnology products. We regularly advise and represent clients in challenges to SPC protection before the UK IPO and the UK Patents Court for products ranging from small molecules to biologies and even medical devices.
Our team’s scientific backgrounds, including PhDs in molecular biology and degrees in biochemistry, together with our knowledge of regulatory law and litigation expertise makes us particularly well suited to devising SPC strategies.